Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Traversa Sergio
Relationship:   Chief Executive Office...
City:   Blue Bell
State:   PA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   247,024    

Indirect Shares

   0      
Direct Value   $924,888    

Indirect Value

   $0      
Total Shares   247,024      
Total Value   $924,888      


Actinium Pharmaceuticals Inc $26,880 Relmada Therapeutics, Inc. $898,008 Actinium Pharmaceuticals Inc $26,880 Relmada Therapeutics, Inc. $898,008
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    2    

     Stock price went up :
    2   
    0    
     Stock price went down :
    2   
    2    
   
     Gain/Loss Ratio :
   0.0   
   -2.0   
     Percentage Gain/Loss :
   10.5%
 -175.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Actinium Pharmaceuticals Inc ATNM Director 2016-04-15 3,000 2013-08-08 0    Premium*  
            Relmada Therapeutics, Inc. RLMD Chief Executive Office... 2024-01-31 244,024 0    Premium*  
* Premium Members only  

Records found :    37         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2020-08-18 4 D $39.03 $162,014 D/D (4,151) 75,493 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2020-08-18 4 OE $3.24 $162,026 D/D 50,008 79,644 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-01-22 4 AS $35.44 $77,213 D/D (2,170) 77,393 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-01-22 4 OE $3.24 $13,187 D/D 4,070 79,563 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-01-25 4 AS $35.29 $45,877 D/D (1,300) 76,093 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-01-26 4 AS $35.15 $21,090 D/D (600) 75,493 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-01-27 4 OE $3.24 $32,400 D/D 10,000 85,493 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-01-27 4 AS $31.77 $323,914 D/D (10,000) 75,493 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-02 4 OE $3.24 $43,030 D/D 13,281 88,774 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-02 4 OE $3.24 $10,621 D/D 3,278 92,052 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-02 4 AS $35.08 $111,470 D/D (3,178) 88,874 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-03 4 AS $35.00 $3,500 D/D (100) 88,874 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-08 4 OE $3.24 $36,307 D/D 11,206 99,980 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-08 4 AS $35.03 $116,049 D/D (3,313) 96,667 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-09 4 AS $35.21 $209,939 D/D (5,963) 90,704 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-10 4 AS $35.28 $68,097 D/D (1,930) 88,774 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-11 4 OE $3.24 $4,685 D/D 1,446 90,220 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-11 4 AS $35.43 $51,238 D/D (1,446) 88,774 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-24 4 OE $3.24 $32,400 D/D 10,000 98,774 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-02-24 4 AS $33.69 $342,392 D/D (10,000) 88,774 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-03-09 4 AS $35.42 $250,169 D/D (7,017) 91,757 0 %
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-03-09 4 OE $3.24 $32,400 D/D 10,000 98,774 0 -
RLMD Relmada Therapeutics, Inc... CEO   •       •      –    2021-03-10 4 AS $35.09 $104,676 D/D (2,983) 88,774 0 %
RLMD Relmada Therapeutics, Inc... Chief Executive Officer   •       •      –    2015-12-14 4 B $2.97 $89 D/D 30 320,352 2.73 -
RLMD Relmada Therapeutics, Inc... Chief Executive Officer   •       •      –    2015-12-15 4 B $2.91 $57,792 D/D 18,970 339,322 2.81 -
  37  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us